Loading
PN
Patheon N.V. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LEVY PAUL S, was filed 03 Oct 2016.
Patheon N.V.: what insiders have been doing
This page follows insider dealings at Patheon N.V. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Patheon N.V. The previous disclosure was published on 31 August 2017.
Since 2016, the database holds 11 purchases and 1 sale by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
105
Thresholds
n/a
Buy Volume
€18M
11 ops. · all time
Sell Volume
€86M
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended October 2016 · cache
Income statement
Gross profit486.3M
Net income28.3M
Last declaration on 31 August 2017
Declarations105 total
373,754 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050941:2
286,585 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050944:2
129,595 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050946:2
48,755 shares@ US$35.0088.9% of flowOrdinary SharesSEC:0001209191-17-050945:0
305,094 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050938:2
2,615,089 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050942:2
330,169 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050943:2
566,603 shares@ US$35.00100.0% of flowOrdinary SharesSEC:0001209191-17-050939:1
196,485 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050939:0
70,141 sharesOrdinary SharesSEC:0001209191-17-050937:0
10,966 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050941:0
191,772 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050941:1
13,112 sharesOrdinary SharesSEC:0001209191-17-050947:0
10,306 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050944:0
161,543 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050944:1
245,939 sharesOrdinary SharesSEC:0001209191-17-050950:0
12,552 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050946:0
219,330 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050946:1
7,078 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050938:0
105,800 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050938:1
93,432 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050942:0
906,858 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050942:1
11,231 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050943:0
261,322 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050943:1
12,420 sharesRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050948:0
25 of 105 declarations
About Patheon N.V.
Patheon N.V. is a company that specializes in pharmaceutical development and manufacturing services. It primarily operates on the XNAS stock market.
